| Dr Theresa M Terlecki, | |
|
612 Mocksville Ave, Salisbury, NC 28144-2732 | |
| (704) 210-5434 | |
| Not Available |
| Full Name | Dr Theresa M Terlecki |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 21 Years |
| Location | 612 Mocksville Ave, Salisbury, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801989389 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 2010-00693 (North Carolina) | Secondary |
| 207P00000X | Emergency Medicine | N2837 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Novant Health Forsyth Medical Center | Winston-salem, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Forsyth Emergency Services, P.a. | 1153358171 | 18 |
News Archive
Affymax, Inc. today announced that it has instituted a quiet period to curtail discussions with the investor community and the media in connection with the analysis of Phase 3 results for the investigational drug, Hematide, in four clinical trials (PEARL 1, PEARL 2, EMERALD 1 and EMERALD 2) which evaluated Hematide for the treatment of anemia in chronic renal failure patients.
National groups are calling for a permanent solution to the doctor payment formula and warning about a possible shortage in doctors and impending decline in Medicare payments. The Virginian-Pilot reports: "If Congress doesn't intervene, a funding formula will trigger a 21 percent cut in reimbursements to doctors in the Medicare and Tricare programs on March 1, a group of national organizations warned Thursday. That, the group said, will force doctors to drop out of the programs and make it tougher for elderly and military beneficiaries to get health care.
In the last year, one thing has become clear: we cannot live life without risk. In fact, every part of our daily routines became subject to analysis: How risky is the action and is its value worth the potential cost?
Since the Zika outbreak in Brazil early last year, the virus has spread to 20 countries across the Americas. As of February 3rd, 35 cases of Zika have been reported in the U.S., all of which have been associated with international travel.
Osprey Medical Inc. (ASX: OSP) today announced that it has received U.S. FDA 510(k) clearance for its AVERT™ System.
› Verified 9 days ago
| Entity Name | Wake Forest University Health Sciences |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003803032 PECOS PAC ID: 4486564952 Enrollment ID: O20031105000436 |
News Archive
Affymax, Inc. today announced that it has instituted a quiet period to curtail discussions with the investor community and the media in connection with the analysis of Phase 3 results for the investigational drug, Hematide, in four clinical trials (PEARL 1, PEARL 2, EMERALD 1 and EMERALD 2) which evaluated Hematide for the treatment of anemia in chronic renal failure patients.
National groups are calling for a permanent solution to the doctor payment formula and warning about a possible shortage in doctors and impending decline in Medicare payments. The Virginian-Pilot reports: "If Congress doesn't intervene, a funding formula will trigger a 21 percent cut in reimbursements to doctors in the Medicare and Tricare programs on March 1, a group of national organizations warned Thursday. That, the group said, will force doctors to drop out of the programs and make it tougher for elderly and military beneficiaries to get health care.
In the last year, one thing has become clear: we cannot live life without risk. In fact, every part of our daily routines became subject to analysis: How risky is the action and is its value worth the potential cost?
Since the Zika outbreak in Brazil early last year, the virus has spread to 20 countries across the Americas. As of February 3rd, 35 cases of Zika have been reported in the U.S., all of which have been associated with international travel.
Osprey Medical Inc. (ASX: OSP) today announced that it has received U.S. FDA 510(k) clearance for its AVERT™ System.
› Verified 9 days ago
| Entity Name | Forsyth Emergency Services, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649256983 PECOS PAC ID: 1153358171 Enrollment ID: O20050722000351 |
News Archive
Affymax, Inc. today announced that it has instituted a quiet period to curtail discussions with the investor community and the media in connection with the analysis of Phase 3 results for the investigational drug, Hematide, in four clinical trials (PEARL 1, PEARL 2, EMERALD 1 and EMERALD 2) which evaluated Hematide for the treatment of anemia in chronic renal failure patients.
National groups are calling for a permanent solution to the doctor payment formula and warning about a possible shortage in doctors and impending decline in Medicare payments. The Virginian-Pilot reports: "If Congress doesn't intervene, a funding formula will trigger a 21 percent cut in reimbursements to doctors in the Medicare and Tricare programs on March 1, a group of national organizations warned Thursday. That, the group said, will force doctors to drop out of the programs and make it tougher for elderly and military beneficiaries to get health care.
In the last year, one thing has become clear: we cannot live life without risk. In fact, every part of our daily routines became subject to analysis: How risky is the action and is its value worth the potential cost?
Since the Zika outbreak in Brazil early last year, the virus has spread to 20 countries across the Americas. As of February 3rd, 35 cases of Zika have been reported in the U.S., all of which have been associated with international travel.
Osprey Medical Inc. (ASX: OSP) today announced that it has received U.S. FDA 510(k) clearance for its AVERT™ System.
› Verified 9 days ago
| Entity Name | Rutherford Emergency Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841593647 PECOS PAC ID: 2961681184 Enrollment ID: O20110120000395 |
News Archive
Affymax, Inc. today announced that it has instituted a quiet period to curtail discussions with the investor community and the media in connection with the analysis of Phase 3 results for the investigational drug, Hematide, in four clinical trials (PEARL 1, PEARL 2, EMERALD 1 and EMERALD 2) which evaluated Hematide for the treatment of anemia in chronic renal failure patients.
National groups are calling for a permanent solution to the doctor payment formula and warning about a possible shortage in doctors and impending decline in Medicare payments. The Virginian-Pilot reports: "If Congress doesn't intervene, a funding formula will trigger a 21 percent cut in reimbursements to doctors in the Medicare and Tricare programs on March 1, a group of national organizations warned Thursday. That, the group said, will force doctors to drop out of the programs and make it tougher for elderly and military beneficiaries to get health care.
In the last year, one thing has become clear: we cannot live life without risk. In fact, every part of our daily routines became subject to analysis: How risky is the action and is its value worth the potential cost?
Since the Zika outbreak in Brazil early last year, the virus has spread to 20 countries across the Americas. As of February 3rd, 35 cases of Zika have been reported in the U.S., all of which have been associated with international travel.
Osprey Medical Inc. (ASX: OSP) today announced that it has received U.S. FDA 510(k) clearance for its AVERT™ System.
› Verified 9 days ago
| Entity Name | Gastonia Physician Services Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316367691 PECOS PAC ID: 3870719602 Enrollment ID: O20140730002523 |
News Archive
Affymax, Inc. today announced that it has instituted a quiet period to curtail discussions with the investor community and the media in connection with the analysis of Phase 3 results for the investigational drug, Hematide, in four clinical trials (PEARL 1, PEARL 2, EMERALD 1 and EMERALD 2) which evaluated Hematide for the treatment of anemia in chronic renal failure patients.
National groups are calling for a permanent solution to the doctor payment formula and warning about a possible shortage in doctors and impending decline in Medicare payments. The Virginian-Pilot reports: "If Congress doesn't intervene, a funding formula will trigger a 21 percent cut in reimbursements to doctors in the Medicare and Tricare programs on March 1, a group of national organizations warned Thursday. That, the group said, will force doctors to drop out of the programs and make it tougher for elderly and military beneficiaries to get health care.
In the last year, one thing has become clear: we cannot live life without risk. In fact, every part of our daily routines became subject to analysis: How risky is the action and is its value worth the potential cost?
Since the Zika outbreak in Brazil early last year, the virus has spread to 20 countries across the Americas. As of February 3rd, 35 cases of Zika have been reported in the U.S., all of which have been associated with international travel.
Osprey Medical Inc. (ASX: OSP) today announced that it has received U.S. FDA 510(k) clearance for its AVERT™ System.
› Verified 9 days ago
| Entity Name | Vep Rowan Ed Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780089060 PECOS PAC ID: 6800111311 Enrollment ID: O20150204000629 |
News Archive
Affymax, Inc. today announced that it has instituted a quiet period to curtail discussions with the investor community and the media in connection with the analysis of Phase 3 results for the investigational drug, Hematide, in four clinical trials (PEARL 1, PEARL 2, EMERALD 1 and EMERALD 2) which evaluated Hematide for the treatment of anemia in chronic renal failure patients.
National groups are calling for a permanent solution to the doctor payment formula and warning about a possible shortage in doctors and impending decline in Medicare payments. The Virginian-Pilot reports: "If Congress doesn't intervene, a funding formula will trigger a 21 percent cut in reimbursements to doctors in the Medicare and Tricare programs on March 1, a group of national organizations warned Thursday. That, the group said, will force doctors to drop out of the programs and make it tougher for elderly and military beneficiaries to get health care.
In the last year, one thing has become clear: we cannot live life without risk. In fact, every part of our daily routines became subject to analysis: How risky is the action and is its value worth the potential cost?
Since the Zika outbreak in Brazil early last year, the virus has spread to 20 countries across the Americas. As of February 3rd, 35 cases of Zika have been reported in the U.S., all of which have been associated with international travel.
Osprey Medical Inc. (ASX: OSP) today announced that it has received U.S. FDA 510(k) clearance for its AVERT™ System.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Theresa M Terlecki, Po Box 847408, Dallas, TX 75284-7408 Ph: () - | Dr Theresa M Terlecki, 612 Mocksville Ave, Salisbury, NC 28144-2732 Ph: (704) 210-5434 |
News Archive
Affymax, Inc. today announced that it has instituted a quiet period to curtail discussions with the investor community and the media in connection with the analysis of Phase 3 results for the investigational drug, Hematide, in four clinical trials (PEARL 1, PEARL 2, EMERALD 1 and EMERALD 2) which evaluated Hematide for the treatment of anemia in chronic renal failure patients.
National groups are calling for a permanent solution to the doctor payment formula and warning about a possible shortage in doctors and impending decline in Medicare payments. The Virginian-Pilot reports: "If Congress doesn't intervene, a funding formula will trigger a 21 percent cut in reimbursements to doctors in the Medicare and Tricare programs on March 1, a group of national organizations warned Thursday. That, the group said, will force doctors to drop out of the programs and make it tougher for elderly and military beneficiaries to get health care.
In the last year, one thing has become clear: we cannot live life without risk. In fact, every part of our daily routines became subject to analysis: How risky is the action and is its value worth the potential cost?
Since the Zika outbreak in Brazil early last year, the virus has spread to 20 countries across the Americas. As of February 3rd, 35 cases of Zika have been reported in the U.S., all of which have been associated with international travel.
Osprey Medical Inc. (ASX: OSP) today announced that it has received U.S. FDA 510(k) clearance for its AVERT™ System.
› Verified 9 days ago
Dr. Edward Parker Hays Jr., MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 612 Mocksville Ave, Salisbury, NC 28144 Phone: 704-210-5000 | |
Dr. Theodore John Sikorski, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 850 Jake Alexander Blvd W, Suite G #148, Salisbury, NC 28147 Phone: 504-903-3549 | |
Dr. Rosa Katharine Gigliotti, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 612 Mocksville Ave, Salisbury, NC 28144 Phone: 704-210-5000 | |
Jeanea R Hundley, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 612 Mocksville Ave, Salisbury, NC 28144 Phone: 704-210-5190 | |
John Campbell Freeman, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 612 Mocksville Ave, Salisbury, NC 28144 Phone: 704-210-5000 | |
Janet Marie Weinberger, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 910 E Innes St, Salisbury, NC 28144 Phone: 980-330-6898 Fax: 980-330-6899 | |
Dr. Joseph Cruz, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 612 Mocksville Ave, Salisbury, NC 28144 Phone: 704-210-5335 |